Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.2M Sell
450,801
-2,510
-0.6% -$256K 0.01% 1219
2025
Q4
$45.6M Buy
453,311
+48,758
+12% +$4.81M 0.01% 1219
2025
Q3
$35M Buy
404,553
+58,047
+17% +$4.59M 0.01% 1383
2025
Q2
$26.4M Buy
346,506
+28,742
+9% +$2.1M ﹤0.01% 1514
2025
Q1
$22.5M Sell
317,764
-5,805
-2% -$454K ﹤0.01% 1576
2024
Q4
$25.3M Buy
323,569
+7,742
+2% +$723K ﹤0.01% 1569
2024
Q3
$32.3M Buy
315,827
+50,536
+19% +$4.19M 0.01% 1411
2024
Q2
$20.1M Buy
265,291
+23,247
+10% +$1.65M ﹤0.01% 1679
2024
Q1
$18.2M Buy
242,044
+5,163
+2% +$411K ﹤0.01% 1668
2023
Q4
$17.4M Buy
236,881
+38,895
+20% +$2.41M ﹤0.01% 1677
2023
Q3
$9.1M Buy
197,986
+131,296
+197% +$5.83M ﹤0.01% 1963
2023
Q2
$2.81M Buy
66,690
+9,575
+17% +$362K ﹤0.01% 2449
2023
Q1
$1.49M Buy
57,115
+545
+1% +$16.1K ﹤0.01% 2603
2022
Q4
$1.68M Buy
56,570
+11,073
+24% +$309K ﹤0.01% 2620
2022
Q3
$885K Buy
45,497
+4,776
+12% +$79.9K ﹤0.01% 2826
2022
Q2
$553K Sell
40,721
-3,708
-8% -$39.2K ﹤0.01% 3037
2022
Q1
$618K Buy
44,429
+17,257
+64% +$251K ﹤0.01% 3039
2021
Q4
$518K Buy
27,172
+1,144
+4% +$25.5K ﹤0.01% 3132
2021
Q3
$587K Buy
+26,028
New +$755K ﹤0.01% 3092

Other funds holding NUVL

Charles Schwab's NUVL Position: Q1 2026 in Review

Charles Schwab reduced its Nuvalent (NUVL) stake by 0.55% in Q1 2026, selling an estimated $256K and leaving 450,801 shares worth $46.2M. The position accounts for 0.01% of the portfolio, ranked #1219.

Charles Schwab first reported a position in NUVL in Q3 2021 and has held it in 19 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Charles Schwab held 450,801 shares of Nuvalent worth $46.2M as of Q1 2026.
  • Charles Schwab sold 2,510 Nuvalent shares in Q1 2026, an estimated $256K.
  • Nuvalent made up 0.01% of Charles Schwab's portfolio in Q1 2026, its #1219 holding.
  • Charles Schwab first reported a position in Nuvalent in Q3 2021 and has held it in 19 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.